Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Filings for Investigator-Led Trials Log 6-Fold Increase in 6 Years: PMDA Official
July 17, 2015
- Government’s Council Finalizes Policy Proposal for Promoting Genomic Medicines for Rare Diseases, Diabetes
July 16, 2015
- Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 2
July 15, 2015
- MHLW Starts Seeking Drug Development Requests under New Scheme
July 14, 2015
- Council OKs Applications Based on Data from Public Domain for 3 Drugs Including Lidocaine
July 14, 2015
- Govt, Pharma Leaders to Meet in August for Drafting of “Comprehensive Strategy”
July 13, 2015
- Q&A Document on GMP for APIs Reaches Step 4: ICH Meeting in Fukuoka
July 13, 2015
- MHLW to Seek “Candidate Drug Lists” for Patient-Initiated Mixed Care from Medical Societies
July 9, 2015
- FY2015 Survey on Generic Use to Get Underway, Results Out in Autumn
July 9, 2015
- JPMA to Cooperate in AMED’s DISC Project: President
July 9, 2015
- Govt to Stockpile Enough Cell Culture-Based H5N1 Pre-Pandemic Vaccines from Kaketsuken for 2.5 Million People
July 9, 2015
- Heart Failure Added to Clinically Significant ADR List for Xalkori
July 8, 2015
- MHLW Calls for Revision of Package Insert for Influenza HA Vaccine, Others
July 8, 2015
- Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 1
July 8, 2015
- Govt to Stockpile Pre-Pandemic Flu Vaccine Based on Indonesia Strain in FY2015
July 7, 2015
- Editor’s Pick: Five Healthcare News Headlines for June 22 - July 5
July 6, 2015
- MHLW Approves Gilead’s Harvoni, Other Products
July 6, 2015
- NCC Eyes Trial Enrollment of 150 Rare Cancer Patients under Registry Initiative
July 3, 2015
- Official Denies Report, Says Govt Won’t Ask Research-Driven Firms to Make Generics
July 3, 2015
- MHLW to Accept Applications for Sakigake Designation for Regenerative Medicine Products, Medical Devices from Sept. 14
July 3, 2015
ページ
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…